1. Home
  2. CNTB vs CLST Comparison

CNTB vs CLST Comparison

Compare CNTB & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • CLST
  • Stock Information
  • Founded
  • CNTB 2012
  • CLST 1922
  • Country
  • CNTB United States
  • CLST United States
  • Employees
  • CNTB N/A
  • CLST N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • CLST
  • Sector
  • CNTB Health Care
  • CLST
  • Exchange
  • CNTB Nasdaq
  • CLST Nasdaq
  • Market Cap
  • CNTB 54.4M
  • CLST 51.8M
  • IPO Year
  • CNTB 2021
  • CLST N/A
  • Fundamental
  • Price
  • CNTB $1.81
  • CLST $12.58
  • Analyst Decision
  • CNTB Strong Buy
  • CLST
  • Analyst Count
  • CNTB 2
  • CLST 0
  • Target Price
  • CNTB $7.50
  • CLST N/A
  • AVG Volume (30 Days)
  • CNTB 168.9K
  • CLST 2.6K
  • Earning Date
  • CNTB 08-13-2025
  • CLST 07-24-2025
  • Dividend Yield
  • CNTB N/A
  • CLST N/A
  • EPS Growth
  • CNTB N/A
  • CLST N/A
  • EPS
  • CNTB N/A
  • CLST 0.58
  • Revenue
  • CNTB $1,965,000.00
  • CLST $11,354,000.00
  • Revenue This Year
  • CNTB N/A
  • CLST N/A
  • Revenue Next Year
  • CNTB N/A
  • CLST N/A
  • P/E Ratio
  • CNTB N/A
  • CLST $21.75
  • Revenue Growth
  • CNTB N/A
  • CLST 164.54
  • 52 Week Low
  • CNTB $0.51
  • CLST $10.67
  • 52 Week High
  • CNTB $2.86
  • CLST $14.23
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 46.67
  • CLST 59.79
  • Support Level
  • CNTB $1.77
  • CLST $12.51
  • Resistance Level
  • CNTB $2.46
  • CLST $12.66
  • Average True Range (ATR)
  • CNTB 0.27
  • CLST 0.05
  • MACD
  • CNTB -0.07
  • CLST 0.01
  • Stochastic Oscillator
  • CNTB 5.80
  • CLST 63.39

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: